Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000529138 | SCV000651862 | likely benign | BAP1-related tumor predisposition syndrome | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000583891 | SCV000687953 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000583891 | SCV001173421 | likely benign | Hereditary cancer-predisposing syndrome | 2015-09-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001548664 | SCV001768616 | likely benign | not provided | 2021-03-02 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000583891 | SCV002537263 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-09 | criteria provided, single submitter | curation | |
Ce |
RCV001548664 | SCV004700653 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | BAP1: BP4, BP7 |